Document:

Exhibit

Exhibit 10.3(b)
Execution Copy

AMENDED AND RESTATED SUPPLEMENTAL AGREEMENT
This AMENDED AND RESTATED SUPPLEMENTAL AGREEMENT (this “Agreement”), dated as of September 21, 2018, is entered into by and among Diversus, Inc., a Delaware corporation (“Diversus”), Positive Physicians Holdings, Inc. a Pennsylvania corporation (the “Company”), Positive Physicians Insurance Exchange, a Pennsylvania domiciled reciprocal inter-insurance exchange (“PPIX”), Physician’s Insurance Program Exchange, a Pennsylvania domiciled reciprocal inter-insurance exchange (“PIPE”), and Professional Casualty Association, a Pennsylvania domiciled reciprocal inter-insurance exchange (“PCA”, and collectively with PPIX and PIPE, or each individually as the context requires, the “Exchanges”), and Insurance Capital Group, LLC (the “Standby Purchaser”).
W I T N E S S E T H:
WHEREAS, the parties hereto entered into a Supplemental Agreement dated June 8, 2018 (the “Supplemental Agreement”); and
WHEREAS, the Supplemental Agreement related to a certain Standby Purchase Agreement dated June 8, 2018 by and among the Exchanges, Diversus and the Standby Purchaser, which is being amended contemporaneously herewith pursuant to an Amendment to Standby Agreement (as amended, the “Standby Agreement”); and
WHEREAS, capitalized terms not otherwise defined in this Agreement shall have the meanings given to them in the Standby Agreement; and
WHEREAS, the parties wish to amend and restate the Supplemental Agreement to reflect the matters that are being amended in the Standby Agreement. 
.
NOW THEREFORE, in consideration of the foregoing and the mutual covenants herein contained, and intending to be legally bound, the parties hereto hereby agree as follows:
Section 1.    Diversus’ Agreements Relating to the Conversion. 
(a)      Diversus agrees to execute and deliver the Diversus Management Agreement and the Merger Option Agreement at the Closing and to cause Diversus Management, Inc. to execute and deliver the Management Agreement at the Closing.
(b)      Diversus agrees to use good faith efforts to negotiate a modification of the terms of the debt of Diversus to its lenders that remains as an obligation of Diversus after giving effect to the repayment by Diversus of $10 million in principal amount of such indebtedness using the proceeds of the payment referenced in Section 8(b)(v) of the Standby Agreement, provided that the terms of such debt are acceptable to Diversus in its reasonable discretion.
(c)      Diversus agrees to use good faith efforts to negotiate the terms of the Loan Agreement, provided the terms of the Loan Agreement are acceptable to Diversus in its sole discretion.

1

Execution Copy

(d)      Diversus agrees to use commercially reasonable efforts to negotiate the Intercreditor Agreement and, provided such Intercreditor Agreement is successfully negotiated, to enter into the Intercreditor Agreement at the Closing. 
Section 2.      Amendments to the Standby Agreement.  Without Diversus’ prior written consent and agreement, which such consent or agreement shall not be unreasonably withheld or delayed,
(a)      no changes may be made to the form or terms of the Diversus Management Agreement or the Merger Option Agreement; and
(b)      no amendments or changes may be made to the Standby Agreement that would (i) alter the terms of the Plans of Conversion, (ii) change the identity of the Standby Purchaser, or (iii) terminate the Standby Agreement other than pursuant to its self-operative terms.
Diversus hereby consents to the Amendment to Standby Stock Purchase Agreement in the form attached hereto as Exhibit A.
Section 3.      Termination Rights.
(a)      This Agreement will terminate automatically upon the termination of the Standby Agreement pursuant to its terms, subject to Section 2(b)(iii) hereof.  In addition, Diversus shall have the right to terminate this Agreement prior to Closing if agreement is not reached on the terms of the amended or restated senior loan documents, the Loan Agreement, or the Intercreditor Agreement so long as Diversus shall have complied with its obligations to negotiate the terms thereof pursuant to Sections 1(b) through 1(d) hereof.
(b)      Shareholder Approval.  Notwithstanding anything to the contrary herein or in the Standby Agreement or any other agreement contemplated hereby or thereby, the parties hereto acknowledge and agree that the obligation of Diversus hereunder to consummate the transactions contemplated by this Agreement, the Standby Agreement or any other agreement contemplated by this Agreement or the Standby Agreement (such agreements, the “Transaction Agreements” and such transactions, the “Transactions”) shall be conditioned upon the receipt of the Shareholder Approval (as defined below).  Diversus covenants to submit the applicable Transaction Agreements and the Transactions to its shareholders within ten (10) days of receipt of a copy of the “Litigation Termination” (defined below).  If Diversus does not receive the Shareholder Approval prior to (i) if such matters are submitted to a vote of shareholders at a meeting thereof called for the purpose of seeking a vote on such matters, the final adjournment of such meeting, or (ii) if such matters are submitted to the shareholders for action by written consent in lieu of a meeting, the earlier of (x) the date, if any, on which Diversus receives written instruments dissenting from such matters such that the Shareholder Approval shall be incapable of being obtained or (y) the close of business on the 30th calendar day following the date on which Diversus first mails any consent solicitation statement or other similar document seeking shareholder action by written consent in lieu of a meeting.  Notwithstanding anything to the contrary herein or in the Standby Agreement or any other agreement contemplated hereby or thereby, the parties hereto acknowledge and agree that, solely in the case that Shareholder Approval is not obtained for the transactions contemplated herein and in the Standby Agreement 

2

Execution Copy

in accordance with the foregoing,  Diversus shall have the right to terminate this Agreement without further liability, obligation, cost or penalty and all of the rights of the parties hereto under this Agreement and the Standby Agreement shall thereupon terminate (other than the right of the Standby Purchaser to receive payment of the No-Vote Termination Fee pursuant to and in accordance with Section 13(e) of the Standby Agreement.  For purposes of this Agreement, the term “Shareholder Approval” shall mean, with respect to the approval of the applicable Transaction Agreements and Transactions, the affirmative vote or written consent of the holders of (i) a majority in voting power of the outstanding shares of capital stock of Diversus entitled to vote thereon and (ii) a majority of the outstanding shares of Series A Preferred Stock, par value $0.0001 per share, entitled to vote thereon.  For purposes of this Agreement, the term “Litigation Termination” shall mean the voluntary dismissal without prejudice of the litigation styled as Enstar Holdings (US) LLC, a Delaware limited liability company, individually, and derivatively on behalf of Nominal Defendant Diversus, Inc., as Plaintiff, v. Gregory Campbell, Scott Penwell, Lewis Sharps, James Zech, ICG and Professional Casualty Holdings, Inc., as Defendants, and Diversus Inc., as Nominal Defendant, in the Court of Chancery of the State of Delaware, C.A. No. 2018-0211-JRS, which dismissal shall be with prejudice as of the Closing. 
Section 4.      Miscellaneous.  This Agreement supersedes the original Supplemental Agreement.  This Agreement may be executed in any number of counterparts, each of which shall be deemed to be an original, but all of which, when taken together, shall constitute one and the same instrument.  In the event that any signature is delivered by facsimile transmission, or by e‐mail delivery of a “.pdf” format data file, such signature shall create a valid and binding obligation of the party executing (or on whose behalf such signature is executed) with the same force and effect as if such facsimile signature page were an original thereof.
[Remainder of this page intentionally left blank.]

3

Execution Copy

IN WITNESS WHEREOF, the parties have caused this Agreement to be duly executed and delivered as of the date first above written.
	
		
	DIVERSUS, INC.

	 
	 

	 
	 

	By:
	/s/ Lewis S. Sharps

	 
	Name: Lewis S. Sharps M.D

	 
	Title: President

	
		
	POSITIVE PHYSICIANS HOLDINGS, INC.

	 
	 

	 
	 

	By:
	/s/ Lewis S. Sharps

	 
	Name: Lewis S. Sharps M.D

	 
	Title: CEO

	
		
	POSITIVE PHYSICIANS INSURANCE EXCHANGE

	 
	 

	 
	 

	By:
	/s/ Lewis S. Sharps

	 
	Name: Lewis S. Sharps M.D

	 
	Title: CEO

	
		
	PHYSICIAN’S INSURANCE PROGRAM EXCHANGE

	 
	 

	 
	 

	By:
	/s/ Lewis S. Sharps

	 
	Name: Lewis S. Sharps M.D

	 
	Title: CEO

	
		
	PROFESSIONAL CASUALTY ASSOCIATION

	 
	 

	 
	 

	By:
	/s/ Lewis S. Sharps

	 
	Name: Lewis S. Sharps M.D

	 
	Title:

4

Execution Copy

	
		
	INSURANCE CAPITAL GROUP, LLC

	By:
	ICG Management, LLC, its managing member

	 
	 

	 
	 

	By:
	/s/ Craig A. Huff

	 
	Name:  Craig A. Huff

	 
	Title:  Co-Managing Member

	 
	 

	 
	 

	By:
	/s/ Matthew T. Popoli

	 
	Name:  Matthew T. Popoli

	 
	Title:  Co-Managing Member

5EX-10.1

 Exhibit 10.1 

Targa Resources Corp. 2019 Annual Incentive Compensation Plan Description 

On January 17, 2019, the Compensation Committee (the “Committee”) of the Board of Directors of Targa Resources Corp.
(the “Company”), the indirect parent of the general partner of Targa Resources Partners LP (the “Partnership”), approved the Company’s 2019 Annual Incentive Compensation Plan (the “Bonus
Plan”). The Bonus Plan is a discretionary annual cash bonus plan available to all of the Company’s employees, including its executive officers, who also serve as officers of the Partnership’s general partner. The purpose of the
Bonus Plan is to reward employees for contributions toward the Company’s business priorities (including business priorities with respect to the Partnership) approved by the Committee and to aid the Company in retaining and motivating employees.
Under the Bonus Plan, the level of funding of the discretionary cash bonus pool is based on the Company’s achievement of certain business priorities, including strategic, financial and operational objectives. 

The Committee has established the following eight key business priorities for 2019: 

 

	 	•	 	 execute on all business dimensions, including the 2019 business plan and public guidance, 

 

	 	•	 	 continue priority emphasis and strong performance relative to a safe workplace, 

 

	 	•	 	 reinforce business philosophy and mindset that promotes compliance in all aspects of our business including
environmental and regulatory compliance, 

  

	 	•	 	 continue to attract and retain the operational and professional talent needed in our businesses,

  

	 	•	 	 continue to control all costs—operating, capital and general and administrative—consistent with
existing business environment, 

  

	 	•	 	 execute on major capital and development projects—finalizing negotiations, completing projects on time and
on budget, optimizing economics and capital funding, and staffing for the new facilities, 

  

	 	•	 	 pursue selected growth opportunities including gathering and processing build outs, fee-based capex projects, and potential purchases of strategic assets, and 

  

	 	•	 	 pursue commercial and financial approaches to achieve maximum value and manage risks, including contract, credit,
inventory, interest rate and commodity price exposures. 

 The Committee has targeted a total cash bonus pool for
achievement of the business priorities based on the sum of individual employee market-based target bonus opportunities, which are based on a percentage of each employee’s eligible earnings. Generally, eligible earnings are an employee’s
base salary and overtime pay. Near or following the end of the year, the Chief Executive Officer (“CEO”) recommends to the Committee the total amount of cash to be allocated to the bonus pool based upon overall performance of the
Company relative to the established objectives, generally ranging from 0 to 2x the aggregate target bonus opportunities for all employees in the pool. Upon receipt of the CEO’s recommendation, the Committee, in its sole discretion, determines
the total amount of cash to be allocated to the bonus pool. The Committee has discretion to adjust the cash bonus pool attributable to the business priorities based on accomplishment of the applicable objectives as determined by the Committee and
the CEO. Additionally, the Committee, in its sole discretion, determines the amount of the cash bonus awards to each of the Company’s executive officers, including the CEO. The executive officers determine the amount of the cash bonus pool to
be allocated to the Company’s departments, groups and employees (other than the executive officers of the Company) based on performance and upon the recommendation of supervisors, managers and line officers.

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00291-of-00352.parquet"}]]